Literature DB >> 26261587

Anti-hypertensive effect of Lycium barbarum L. with down-regulated expression of renal endothelial lncRNA sONE in a rat model of salt-sensitive hypertension.

Xinyu Zhang1, Xinping Yang2, Yahui Lin3, Miaomiao Suo3, Ling Gong3, Jingzhou Chen3, Rutai Hui3.   

Abstract

The present study aims to test whether Lycium barbarum L. has anti-hypertensive effect through regulating expression of lncRNA sONE in a rat model of salt-sensitive hypertension. Nine weeks old borderline hypertensive rats (BHRs) were divided into 4 groups receiving high (8% NaCl), medium (0.25% NaCl, as control group), and low salt diet (0.015% NaCl) for 16 weeks, respectively, while the fourth group (high salt + L. barbarum group) fed with high salt diet for 12 weeks, then followed by 8% NaCl and L. barbarum treatment for 4 weeks. Body weight and blood pressure were recorded biweekly. Salt-sensitive hypertension was successfully induced by 12-week high salt diet in BHR model. Blood pressure was significantly increased in the model (P < 0.05), and L. barbarum treatment reversed the elevated blood pressure to normal level. Expression of lncRNA sONE was significantly reduced and eNOS expression level was dramatically improved in the hypertension model rats with the L. barbarum compared with that receiving high salt diet. Our results indicated that L. barbarum L. had anti-hypertensive effect and might lower blood pressure by suppressing the expression of lncRNA sONE in BHR model.

Entities:  

Keywords:  Lycium barbarum L.; endothelial nitric oxide synthase; lncRNA sONE; salt-sensitive hypertension

Mesh:

Substances:

Year:  2015        PMID: 26261587      PMCID: PMC4525921     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  28 in total

1.  Salt intake affects the relation between hypertension and the T-786C polymorphism in the endothelial nitric oxide synthase gene.

Authors:  Koichi Miyaki; Shugo Tohyama; Mitsuru Murata; Haruhito Kikuchi; Izumi Takei; Kiyoaki Watanabe; Kazuyuki Omae
Journal:  Am J Hypertens       Date:  2005-12       Impact factor: 2.689

2.  Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man.

Authors:  P Vallance; J Collier; S Moncada
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

3.  Nicorandil suppresses urinary protein excretion and activates eNOS in Dahl salt-sensitive hypertensive rats.

Authors:  Yoshihito Tashiro; Kenji Yogo; Kenichi Serizawa; Koichi Endo
Journal:  Clin Exp Nephrol       Date:  2014-06-22       Impact factor: 2.801

Review 4.  Nitric oxide, caveolae, and vascular pathology.

Authors:  Xiang-An Li; William Everson; Eric J Smart
Journal:  Cardiovasc Toxicol       Date:  2006       Impact factor: 3.231

5.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase.

Authors:  P L Huang; Z Huang; H Mashimo; K D Bloch; M A Moskowitz; J A Bevan; M C Fishman
Journal:  Nature       Date:  1995-09-21       Impact factor: 49.962

6.  Post-transcriptional regulation of endothelial nitric-oxide synthase by an overlapping antisense mRNA transcript.

Authors:  G Brett Robb; Andrew R Carson; Sharon C Tai; Jason E Fish; Sundeep Singh; Takahiro Yamada; Stephen W Scherer; Kazuhiko Nakabayashi; Philip A Marsden
Journal:  J Biol Chem       Date:  2004-07-02       Impact factor: 5.157

7.  Renal manifestations of NaCl sensitivity in borderline hypertensive rats.

Authors:  G F DiBona; S Y Jones
Journal:  Hypertension       Date:  1991-01       Impact factor: 10.190

8.  Genome-wide association study of blood pressure and hypertension.

Authors:  Daniel Levy; Georg B Ehret; Kenneth Rice; Germaine C Verwoert; Lenore J Launer; Abbas Dehghan; Nicole L Glazer; Alanna C Morrison; Andrew D Johnson; Thor Aspelund; Yurii Aulchenko; Thomas Lumley; Anna Köttgen; Ramachandran S Vasan; Fernando Rivadeneira; Gudny Eiriksdottir; Xiuqing Guo; Dan E Arking; Gary F Mitchell; Francesco U S Mattace-Raso; Albert V Smith; Kent Taylor; Robert B Scharpf; Shih-Jen Hwang; Eric J G Sijbrands; Joshua Bis; Tamara B Harris; Santhi K Ganesh; Christopher J O'Donnell; Albert Hofman; Jerome I Rotter; Josef Coresh; Emelia J Benjamin; André G Uitterlinden; Gerardo Heiss; Caroline S Fox; Jacqueline C M Witteman; Eric Boerwinkle; Thomas J Wang; Vilmundur Gudnason; Martin G Larson; Aravinda Chakravarti; Bruce M Psaty; Cornelia M van Duijn
Journal:  Nat Genet       Date:  2009-05-10       Impact factor: 38.330

9.  Hypertension produced by a high sodium diet in the borderline hypertensive rat (BHR).

Authors:  J E Lawler; B J Sanders; Y F Chen; S Nagahama; S Oparil
Journal:  Clin Exp Hypertens A       Date:  1987

Review 10.  Salt sensitivity of blood pressure in humans.

Authors:  M H Weinberger
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

View more
  14 in total

1.  Long noncoding RNAs and sulforaphane: a target for chemoprevention and suppression of prostate cancer.

Authors:  Laura M Beaver; Rachael Kuintzle; Alex Buchanan; Michelle W Wiley; Sarah T Glasser; Carmen P Wong; Gavin S Johnson; Jeff H Chang; Christiane V Löhr; David E Williams; Roderick H Dashwood; David A Hendrix; Emily Ho
Journal:  J Nutr Biochem       Date:  2017-01-12       Impact factor: 6.048

2.  Identification of lncRNA-NR_104160 as a biomarker and construction of a lncRNA-related ceRNA network for essential hypertension.

Authors:  Wenjuan Peng; Han Cao; Kuo Liu; Chunyue Guo; Yanyan Sun; Han Qi; Zheng Liu; Yunyi Xie; Xiaohui Liu; Bingxiao Li; Ling Zhang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  Identification of long non-coding RNAs in the immature and mature rat anterior pituitary.

Authors:  Dong-Xu Han; Xu-Lei Sun; Yao Fu; Chang-Jiang Wang; Jian-Bo Liu; Hao Jiang; Yan Gao; Cheng-Zhen Chen; Bao Yuan; Jia-Bao Zhang
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

Review 4.  Non-Coding RNA in the Pathogenesis, Progression and Treatment of Hypertension.

Authors:  Christiana Leimena; Hongyu Qiu
Journal:  Int J Mol Sci       Date:  2018-03-21       Impact factor: 5.923

5.  Down-regulation of lncRNA MALAT1 alleviates vascular lesion and vascular remodeling of rats with hypertension.

Authors:  Yu-Zeng Xue; Zhi-Juan Li; Wei-Tao Liu; Jin-Jiao Shan; Lei Wang; Qian Su
Journal:  Aging (Albany NY)       Date:  2019-07-25       Impact factor: 5.682

6.  CeRNA network analysis and functional enrichment of salt sensitivity of blood pressure by weighted-gene co-expression analysis.

Authors:  Han Cao; Han Qi; Zheng Liu; Wen-Juan Peng; Chun-Yue Guo; Yan-Yan Sun; Christine Pao; Yu-Tao Xiang; Ling Zhang
Journal:  PeerJ       Date:  2019-09-13       Impact factor: 2.984

Review 7.  Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders.

Authors:  Birgit Waltenberger; Andrei Mocan; Karel Šmejkal; Elke H Heiss; Atanas G Atanasov
Journal:  Molecules       Date:  2016-06-22       Impact factor: 4.411

8.  Construction of a ceRNA coregulatory network and screening of hub biomarkers for salt-sensitive hypertension.

Authors:  Ling Zhang; Han Qi; Zheng Liu; Wen-Juan Peng; Han Cao; Chun-Yue Guo; Yan-Yan Sun; Christine Pao; Yu-Tao Xiang
Journal:  J Cell Mol Med       Date:  2020-05-15       Impact factor: 5.310

9.  The predictive utility of the plant phylogeny in identifying sources of cardiovascular drugs.

Authors:  Emily Guzman; Jeanmaire Molina
Journal:  Pharm Biol       Date:  2018-12       Impact factor: 3.503

10.  A Novel lncRNA Regulates the Toll-Like Receptor Signaling Pathway and Related Immune Function by Stabilizing FOS mRNA as a Competitive Endogenous RNA.

Authors:  Hao Fan; Zengpeng Lv; Liping Gan; Chao Ning; Zhui Li; Minghui Yang; Beibei Zhang; Bochen Song; Guang Li; Dazhi Tang; Jinxin Gao; Shaojia Yan; Youli Wang; Jianfeng Liu; Yuming Guo
Journal:  Front Immunol       Date:  2019-04-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.